Drug News: May 2014A review of launches, new indications, Health Canada advisories and new dosage guidelines Invokana: first sodium-glucose co-transporter 2 inhibitor for type 2 diabetesReduces plasma glucose by decreasing renal reabsorption and increasing urinary excretion of glucose. Specialty drug spend unsustainable Spending on specialty drugs is likely to increase at a significant rate, substantially impacting the cost employers pay, according to a report. OPA urges members to support parties that share profession’s vision Association puts forward three priorities to promote to all party candidates. Stateside: Witness a pharmacist union in action Group in row with insurer and pharmacy operator over pensions, rushed patient interactions. Europe: Pharmacy's closure exposes holes in U.K. care home supply Drugstores scramble to fill void left by bankruptcy of Pharmacy Plus. Stateside: New video helps identify those who abuse prescription drugs Production titled Red Flags was unveiled earlier this month. Press Review – May 26, 2014 Fentanyl scam uncovered in Ontario Health centre receptionist sentenced to nine years would verify forged prescriptions when pharmacies called to double-check orders. Updated Canadian statement on herpes zoster vaccine First Previous 808 809 810 811 812 Next Last
